Heersink Institute Leadership Attend Symposium on AI in Health Care at Maastricht University
Written by Emily Liming Johns
University of Alabama at Birmingham (UAB) faculty members recently participated in the AI in Medicine and Healthcare Symposium at Maastricht University, which brought together experts and stakeholders to discuss the role of artificial intelligence (AI) in transforming health care.
Newsom completes Phase 2 clinical trial of a novel drug for Pitt-Hopkins Syndrome
Written by Mary Ashley Canevaro
Cassandra Newsom, Psy.D., director of the Translational Research Core in Autism and Neurodevelopment of Civitan International Research Center, has completed participation in Phase 2 Clinical Trials of a new drug, NNZ-2591, that shows promising results for a devastating neurodevelopmental disorder called Pitt-Hopkins Syndrome (PTHS).
Two researchers named Emerging Scholar Award winners for 2024-2025
Written by Mary Ashley Canevaro and Joy Marsch
Two researchers have been named Civitan Emerging Scholars for 2024-2025 by the Civitan International Research Center for neurodevelopmental disorders.
2024 Juneteenth Commemoration Recap: connecting art and history with health and healing
Written by Holly Dunn
Hepatitis B in Africa: New Tools and Progress Toward Elimination with Jodie Dionne, M.D., and Michael Vinikoor, M.D.
Written by Emily Liming Johns
Pride Month spotlight: how ODI’s LGBTQ+ Faculty Association promotes inclusive healthcare at UAB year-round
Written by Holly Dunn
The Heersink School of Medicine Office for Diversity and Inclusion LGBTQ+ Faculty Association wants to wish you a happy Pride Month. The worldwide commemoration of LGBTQ+ culture and rights kicked off on June 1 with events around the globe celebrating progress made in the LGBTQ+ civil rights movement.